Argitalpenak (66) Ikertzaileren baten partaidetza izan duten argitalpenak

2017

  1. 11C-Methionine-PET in multiple myeloma: A combined study from two different institutions

    Theranostics, Vol. 7, Núm. 11, pp. 2956-2964

  2. A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials

    Leukemia, Vol. 31, Núm. 2, pp. 318-324

  3. A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients

    Journal of Translational Medicine, Vol. 15, Núm. 1

  4. An in-silico approach to predict and exploit synthetic lethality in cancer metabolism

    Nature Communications, Vol. 8, Núm. 1

  5. Antibody-dependent cell cytotoxicity: Immunotherapy strategies enhancing effector NK cells

    Immunology and Cell Biology, Vol. 95, Núm. 4, pp. 347-355

  6. Antitumor effect of an adeno-associated virus expressing apolipoprotein A-1 fused to interferon alpha in an interferon alpha-resistant murine tumor model

    Oncotarget, Vol. 8, Núm. 3, pp. 5247-5255

  7. Arterial spin labeling MRI is able to detect early hemodynamic changes in diabetic nephropathy

    Journal of Magnetic Resonance Imaging, Vol. 46, Núm. 6, pp. 1810-1817

  8. BCL6 antagonizes NOTCH2 to maintain survival of human follicular lymphoma cells

    Cancer Discovery, Vol. 7, Núm. 5, pp. 506-521

  9. Bone Marrow Stroma and Vascular Contributions to Myeloma Bone Homing

    Current Osteoporosis Reports, Vol. 15, Núm. 5, pp. 499-506

  10. Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial

    The Lancet, Vol. 390, Núm. 10094, pp. 555-566

  11. CM352 reduces brain damage and improves functional recovery in a rat model of intracerebral hemorrhage

    Journal of the American Heart Association, Vol. 6, Núm. 6

  12. CREBBP inactivation promotes the development of HDAC3-dependent lymphomas

    Cancer Discovery, Vol. 7, Núm. 1, pp. 38-53

  13. Cellular immunotherapies for cancer

    OncoImmunology, Vol. 6, Núm. 5

  14. Chronic lymphocytic leukemia with isochromosome 17q: An aggressive subgroup associated with TP53 mutations and complex karyotypes

    Cancer Letters, Vol. 409, pp. 42-48

  15. Clinical perspectives on the management of bleeding in patients on oral anticoagulants: The DECOVER Study (DElphi Consensus on oral COagulation and therapy action reVERsa

    Emergencias, Vol. 29, Núm. 1, pp. 18-26

  16. Combined PI3K/Akt and Smad2 activation promotes corneal endothelial cell proliferation

    Investigative Ophthalmology and Visual Science, Vol. 58, Núm. 2, pp. 745-754

  17. Commentary on Pharmacometrics for Immunotherapy

    CPT: Pharmacometrics and Systems Pharmacology, Vol. 6, Núm. 1, pp. 8-10

  18. Current applications of multiparameter flow cytometry in plasma cell disorders This article has been corrected since Online Publication and an Erratum has also been published

    Blood Cancer Journal, Vol. 7, Núm. 10

  19. Current management of patients with chronic myelomonocytic leukemia

    Current Opinion in Oncology, Vol. 29, Núm. 1, pp. 79-87

  20. Cytokine-loaded PLGA and PEG-PLGA microparticles showed similar heart regeneration in a rat myocardial infarction model

    International Journal of Pharmaceutics, Vol. 523, Núm. 2, pp. 531-533